Skip to main content
. 2022 Sep 21;13:967822. doi: 10.3389/fendo.2022.967822

Figure 9.

Figure 9

(A-L) Validation of key targets by qRT-PCR (n=6). Data are presented as the mean ± SE. *P < 0.05; **P < 0.001. CR, control group; DN, diabetic nephropathy group; DG, dapagliflozin group.